Exabis Library
Welcome to the e-CCO Library!
P241: Advantages of a fully automated chemiluminescent method for therapeutic drug monitoring (TDM) of anti-TNFα in patients with Inflammatory Bowel Diseases.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P241: Defining patient-centered outcomes for IBD – an international, cross-disciplinary consensus
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P241: Focussing on the future: reducing barriers and improving access to IBD specialty care
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P241: Gastrointestinal ultrasonography diagnostic performance and feasibility in IBD during pregnancy: a systematic review and narrative synthesis.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P241: Gastrointestinal ultrasound instead of magnetic resonance enterography: Large potential cost savings with limited clinical downsides
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P241: Predictive factors of bone loss in inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P241: Risk factors associated with perianal Crohn’s disease in Korean children
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P242 Prior pregnancy outcome is an important determinant of subsequent pregnancy outcome in women with inflammatory bowel diseases
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P242: Accuracy of Doppler transabdominal ultrasound in assessing disease severity and extent in IBD
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P242: Latent Tuberculosis: frequency of occurrence and effect on clinical, laboratory, endoscopic and morphological activity of the course Inflammatory Bowel Diseases
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P242: Newly diagnosed Inflammatory Bowel Disease patients referred via the Straight To Test Lower GI two week wait pathway, Single Centre Study.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P242: Performance of the BÜHLMANN Quantum Blue® Infliximab point-of-care assay dedicated for therapeutic drug monitoring of serum infliximab trough levels
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P242: Phenotypic characterisation of elderly – onset inflammatory bowel disease – IBD at the extremes
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P242: The prevalence of sarcopenia and its effect on prognosis in patients with Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P242: Universal exclusion of patients with Permanent Ileostomy in Crohn's disease clinical trials: A systematic review
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P243 Changes in the therapeutic management of inflammatory bowel disease in the biological era – a nationwide retrospective cohort study in three Nordic countries: Results from the TRINordic study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P243: Colectomy rates in ulcerative colitis are low and decreasing: Ten-year follow-up data from the Swiss IBD cohort study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P243: Complications of newly diagnosed Crohn's disease can be predicted by mathematical modeling of serologic responses
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P243: Developing a protocol to conduct a student-driven study across Europe: EuroSurg-1 study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P243: Elevated presepsin levels are a marker of sepsis risk in patients with inflammatory bowel diseases receiving therapy of TNF-α blockers.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM